Agetech

PDL announces results of biological age reduction research

Ponce De Leon Health shares pilot results suggesting that its Rejuvant LifeTabs reduce biological age by an average of 8.5 years. In the pilot, biological...

Easy-peasy Series-B(sy)

Nuritas launches PeptiYouth™ an AI-discovered peptide, clinically proven, anti-aging molecule. Nuritas, a leader in Artificial Intelligence-based peptide discovery, has launched PeptiYouth™, a peptide discovered within peas and which, following clinical trials, has been shown...

Partnership demonstrates government Longevity intervention

PAI Health to support UK's All-Party Parliamentary Group for Longevity in its quest to extend life expectancy and minimise health inequality. Digital health technology company...

Inside is the new outside for DNA and PT collaboration

Working your core means going even deeper - right down to your genes - thanks to PT Hub and Muhdo Health. Biohacking – DIY Biology...

Elysium launches Longevity supplement for brain health

Developed in collaboration with the University of Oxford, MATTER targets brain atrophy associated with age-related memory loss. While many of the developments in the Longevity...

Amazon and K4Connect demonstrate scalability for agetech

Covid-19 has been difficult for everyone, but particularly for people over the age of 65 who may spend months shut away from loved ones...

Real-time tracking of 400+ Longevity biomarkers

Longevity InTime aims to track 400+ biomarkers of health in ‘real time’ ... starting with millionaires (as both users and investors). From wearable devices and...

Biomarkers for aging – a consensus is needed now more than ever

Slowing, stopping and even reversing aging – how can we research progress if we can't measure success? Biomarkers of aging are pretty important in the...

Longevity Leaders World Congress goes virtual

Annual Longevity conference gets a digital makeover as the community adapts to COVID-19. With much of the world still in some form of lockdown, the...

Making the Longevity grade: expanded list of 1000 leading names

2020 list showcases a growing network of Longevity influencers from the worlds of aging research, technology, policy, media and investment. Who's who in Longevity? Following-on...

Classifying aging as a disease – it’s all about the ‘how’

The hurdle of classifying aging as a disease, rather than an inevitability, has started to be overcome. Now Alex Zhavoronkov is pushing for us...

Longevity and the art of motorcycle maintenance

OpenCures' Kevin Perrott talks about empowering the consumer with their own health data. One of the Longevity sector’s leading voices came to the field relatively...

Start-up claims first commercial glycan-based age test

GlycanAge raising £850k to scale up biological age testing. One thing that became abundantly clear during last week’s Longevity2020 online conference was that measuring the...

L&G escalates investment into research for social care

UK's fragile social care system gets an essential boost from Legal & General. The UK has been facing a social care crisis for some time,...

AI, COVID-19 and aging: this time it’s personal

Dr Richard Siow talks COVID-19, its implications for Longevity, and how AI can play a role. Scientists across the world are scrambling in response to...

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Join me at my 100th birthday party in 2049!

We speak with GRG's Johnny Adams, a key contributor to the Longevity2020 online conference, about his quest for more healthy years. Longevity.Technology: The curator on Thursday 30th April...

Call for consensus in defining biological aging

We speak with a key contributor to the Longevity2020 online conference about biological aging. UK start-up AgeCurve is focused on the measurement of aging and...

Early intervention and disease prevention = Longevity

Talking prevention and treatments for Longevity with Prodrome's Dayan Goodenowe. Detecting prodromes – an early indication of a developing condition or disease – could revolutionise...

Home alone: extend life while saving life

Most of us are at home right now - what will it be like when we're older? And what is being done to improve...

Latest articles

VC enters Longevity market with K4Connect deal

We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity. Longevity agetech company K4Connect has announced...

Challenging the one drug/one disease model

A new paper supports the targeting of aging processes, rather than just one disease, to improve Longevity outcomes. Multimorbidity is a challenge for Longevity; defined...

Robotics and AI combine for new therapeutics discovery

Insilico Medicine and Arctoris announce robotics/AI partnership to focus on COVID-19 inhibitors that could have wide-reaching benefits for Longevity. Two companies have joined forces in...

The results are in: sharing our Longevity investment survey

There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details. The global Longevity...